Johnson & Johnson reported Q4 FY 2016 earnings of $1.58 per share (versus $1.44 in Q4 FY 2015), beating analysts’ consensus estimate of $1.56.
The company’s quarterly revenues amounted to $18.106 bln (+1.7% y/y), generally in-line with analysts’ consensus estimate of $18.260 bln.
The company also issued downside guidance for FY 2017, projecting EPS of $6.93-7.08 (versus analysts’ consensus estimate of $7.12) and revenues of $74.1-74.8 bln (versus analysts’ consensus estimate of $75.13 bln).
JNJ fell to $112.28 (-1.43%) in pre-market trading.
The post Company News: Johnson & Johnson (JNJ) Q4 EPS beat analysts’ estimate appeared first on forex-analytics.press.